Kato, N.; Tateishi, K.; Tsubaki, M.; Takeda, T.; Matsumoto, M.; Tsurushima, K.; Ishizaka, T.; Nishida, S.
Gabapentin and Duloxetine Prevent Oxaliplatin- and Paclitaxel-Induced Peripheral Neuropathy by Inhibiting Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Phosphorylation in Spinal Cords of Mice. Pharmaceuticals 2021, 14, 30.
https://doi.org/10.3390/ph14010030
AMA Style
Kato N, Tateishi K, Tsubaki M, Takeda T, Matsumoto M, Tsurushima K, Ishizaka T, Nishida S.
Gabapentin and Duloxetine Prevent Oxaliplatin- and Paclitaxel-Induced Peripheral Neuropathy by Inhibiting Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Phosphorylation in Spinal Cords of Mice. Pharmaceuticals. 2021; 14(1):30.
https://doi.org/10.3390/ph14010030
Chicago/Turabian Style
Kato, Natsuki, Keisuke Tateishi, Masanobu Tsubaki, Tomoya Takeda, Mikihiro Matsumoto, Katsumasa Tsurushima, Toshihiko Ishizaka, and Shozo Nishida.
2021. "Gabapentin and Duloxetine Prevent Oxaliplatin- and Paclitaxel-Induced Peripheral Neuropathy by Inhibiting Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Phosphorylation in Spinal Cords of Mice" Pharmaceuticals 14, no. 1: 30.
https://doi.org/10.3390/ph14010030
APA Style
Kato, N., Tateishi, K., Tsubaki, M., Takeda, T., Matsumoto, M., Tsurushima, K., Ishizaka, T., & Nishida, S.
(2021). Gabapentin and Duloxetine Prevent Oxaliplatin- and Paclitaxel-Induced Peripheral Neuropathy by Inhibiting Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Phosphorylation in Spinal Cords of Mice. Pharmaceuticals, 14(1), 30.
https://doi.org/10.3390/ph14010030
